Getinge AB (GNGBY)
25.20
-0.45
(-1.75%)
USD |
OTCM |
Sep 01, 16:00
Getinge Market Cap : 6.405B for Sept. 1, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 01, 2026 | 6.405B |
| August 31, 2026 | 6.519B |
| August 28, 2026 | 6.519B |
| August 27, 2026 | 6.541B |
| August 26, 2026 | 6.541B |
| August 25, 2026 | 6.541B |
| August 24, 2026 | 6.541B |
| August 21, 2026 | 6.541B |
| August 20, 2026 | 6.557B |
| August 19, 2026 | 6.560B |
| August 18, 2026 | 6.397B |
| August 17, 2026 | 6.387B |
| August 14, 2026 | 6.393B |
| August 13, 2026 | 6.348B |
| August 12, 2026 | 6.348B |
| August 11, 2026 | 6.367B |
| August 10, 2026 | 6.397B |
| August 07, 2026 | 6.359B |
| August 06, 2026 | 6.344B |
| August 05, 2026 | 6.384B |
| August 04, 2026 | 6.394B |
| August 03, 2026 | 6.367B |
| July 31, 2026 | 6.321B |
| July 30, 2026 | 6.294B |
| July 29, 2026 | 6.255B |
| Date | Value |
|---|---|
| July 28, 2026 | 6.163B |
| July 27, 2026 | 6.002B |
| July 24, 2026 | 6.003B |
| July 23, 2026 | 5.951B |
| July 22, 2026 | 6.091B |
| July 21, 2026 | 6.077B |
| July 20, 2026 | 6.072B |
| July 17, 2026 | 6.145B |
| July 16, 2026 | 5.515B |
| July 15, 2026 | 5.472B |
| July 14, 2026 | 5.416B |
| July 13, 2026 | 5.472B |
| July 10, 2026 | 5.459B |
| July 09, 2026 | 5.345B |
| July 08, 2026 | 5.238B |
| July 07, 2026 | 5.396B |
| July 06, 2026 | 5.393B |
| July 02, 2026 | 5.342B |
| July 01, 2026 | 5.286B |
| June 30, 2026 | 5.167B |
| June 29, 2026 | 5.154B |
| June 26, 2026 | 5.143B |
| June 25, 2026 | 5.197B |
| June 24, 2026 | 5.073B |
| June 23, 2026 | 5.025B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Xvivo Perfusion AB | 974.91M |
| Paxman AB | 81.46M |
| Enovis Corp. | 1.163B |
| Edwards Lifesciences Corp. | 52.35B |
| Intuitive Surgical, Inc. | 131.58B |
Market Cap Related Metrics
| PE Ratio | 24.05 |
| PS Ratio | 1.877 |
| PEG Ratio | 0.2453 |
| Price to Book Value | 2.147 |
| Price to Free Cash Flow | 17.05 |
| Price | 25.20 |
| Earnings Yield | 4.16% |
| PEGY Ratio | 0.2404 |
| Operating PE Ratio | 13.86 |
| Normalized PE Ratio | 23.02 |